NASDAQ:GHSI - Guardion Health Sciences News Headlines

$0.25
-0.01 (-3.83 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
$0.2524
Now: $0.2509
$0.2540
50-Day Range
$0.24
MA: $0.97
$2.35
52-Week Range
$0.20
Now: $0.2509
$4.00
Volume2.47 million shs
Average Volume4.72 million shs
Market Capitalization$5.70 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Guardion Health Sciences (NASDAQ GHSI) News Headlines

Source:
DateHeadline
Guardion Health Sciences: Massive Dilution In Less Than A MonthGuardion Health Sciences: Massive Dilution In Less Than A Month
seekingalpha.com - August 21 at 3:34 PM
Guardion boosts price of equity offering; shares ahead 10% premarketGuardion boosts price of equity offering; shares ahead 10% premarket
seekingalpha.com - August 15 at 8:28 PM
Guardion Health Sciences Closes $5.8 Million Underwritten Public OfferingGuardion Health Sciences Closes $5.8 Million Underwritten Public Offering
finance.yahoo.com - August 15 at 8:28 PM
Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public OfferingGuardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering
finance.yahoo.com - August 15 at 9:28 AM
32 Healthcare Stocks Moving In Wednesdays Pre-Market Session32 Healthcare Stocks Moving In Wednesday's Pre-Market Session
www.benzinga.com - August 14 at 11:40 AM
Guardion Health Sciences (NASDAQ:GHSI) Posts Quarterly  Earnings ResultsGuardion Health Sciences (NASDAQ:GHSI) Posts Quarterly Earnings Results
www.americanbankingnews.com - August 13 at 10:54 AM
Guardion down 61% premarket after pricing stock offeringGuardion down 61% premarket after pricing stock offering
seekingalpha.com - August 13 at 10:12 AM
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public OfferingGuardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering
finance.yahoo.com - August 13 at 10:12 AM
Guardion files for upsized stock offeringGuardion files for upsized stock offering
seekingalpha.com - August 12 at 11:10 PM
Guardion Health Sciences Reports June 30, 2019 Interim Results of OperationsGuardion Health Sciences Reports June 30, 2019 Interim Results of Operations
finance.yahoo.com - August 12 at 1:08 PM
Foundation Fighting Blindness selects Guardion’s VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-Center Clinical TrialFoundation Fighting Blindness selects Guardion’s VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-Center Clinical Trial
finance.yahoo.com - August 6 at 10:55 AM
Second Time Is A Charm: Guardion Health Sciences Pops On Patent News For NowSecond Time Is A Charm: Guardion Health Sciences Pops On Patent News For Now
seekingalpha.com - July 22 at 3:23 PM
What Type Of Shareholder Owns Guardion Health Sciences, Inc.'s (NASDAQ:GHSI)?What Type Of Shareholder Owns Guardion Health Sciences, Inc.'s (NASDAQ:GHSI)?
finance.yahoo.com - July 19 at 3:21 PM
Thinking about buying stock in Aurora Cannabis, Blue Apron, Bank of America, Francescas, or Guardion Health Sciences?Thinking about buying stock in Aurora Cannabis, Blue Apron, Bank of America, Francesca's, or Guardion Health Sciences?
www.marketwatch.com - July 17 at 3:20 PM
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the Hong Kong Patents RegistryGuardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the Hong Kong Patents Registry
finance.yahoo.com - July 17 at 7:37 AM
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the European UnionGuardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the European Union
finance.yahoo.com - June 20 at 10:52 AM
Guardion Launches Second Ocular Health Formula ‘GlaucoCetin’Guardion Launches Second Ocular Health Formula ‘GlaucoCetin’
finance.yahoo.com - June 4 at 3:19 PM
Guardion’s Lumega-Z Formula Associated with Substantial Clinical Improvement in Patients Contrast Sensitivity Visual Function (CSF) vs AREDS 2Guardion’s Lumega-Z Formula Associated with Substantial Clinical Improvement in Patients Contrast Sensitivity Visual Function (CSF) vs AREDS 2
finance.yahoo.com - May 9 at 3:16 PM
Guardion Health Sciences Inc.Guardion Health Sciences Inc.
www.barrons.com - May 3 at 6:08 PM
This page was last updated on 8/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel